As of September 29, 2026, OKYO Pharma's top three insider holders are Gabriele M Cerrone (Director, 10.87Mn shares), Gabriele M Cerrone (Executive Chairman, 9.18Mn shares), Gary S Jacob (Chief Development Officer, 112.42K shares).
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Gabriele M Cerrone | Director, TenPercentOwner | 0 | 20,114,319 | 20,114,319 | 98.9% | 07 Aug, 2026 |
| 2 | Gary S Jacob | Chief Development Officer | 124,920 | 0 | 124,920 | 0.6% | 07 Aug, 2026 |
| 3 | John P Brancaccio | Director | 51,871 | 0 | 51,871 | 0.3% | 07 Aug, 2026 |
| 4 | Rajkumar V. Patil | Chief Scientific Officer | 20,030 | 0 | 20,030 | 0.1% | 07 Aug, 2026 |
| 5 | Flavio Mantelli | Chief Medical Officer | 20,000 | 0 | 20,000 | 0.1% | 07 Aug, 2026 |
| 6 | Robert John Dempsey | Chief Executive Officer | 15,000 | 0 | 15,000 | 0.1% | 07 Aug, 2026 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 20 Jul, 2026 | Gabriele M Cerrone | Director, TenPercentOwner | Acquired P | 25,000 | $1.40 | $35.00K | 10,851,416 | Indirect |
| 21 Jul, 2026 | Gabriele M Cerrone | Director, TenPercentOwner | Acquired P | 22,500 | $1.45 | $32.63K | 10,873,916 | Indirect |
| 21 Jul, 2026 | John P Brancaccio | Director | Acquired P | 5,000 | $1.48 | $7.39K | 35,201 | Direct |
| 21 Jul, 2026 | Gary S Jacob | Chief Development Officer | Acquired P | 3,500 | $1.40 | $4.90K | 112,420 | Direct |
| 21 Jul, 2026 | Flavio Mantelli | Chief Medical Officer | Acquired P | 20,000 | $1.40 | $28.00K | 20,000 | Direct |
| 22 Jul, 2026 | Robert John Dempsey | Chief Executive Officer | Acquired P | 15,000 | $1.54 | $23.09K | 15,000 | Direct |
| 27 Jul, 2026 | Rajkumar V. Patil | Chief Scientific Officer | Acquired P | 3,363 | $1.49 | $5.01K | 20,030 | Direct |
| 27 Jul, 2026 | Rajkumar V. Patil | Chief Scientific Officer | Acquired A | 3,363 | $1.49 | $5.01K | 20,030 | Direct |
| 21 Jul, 2026 | John P Brancaccio | Director | Acquired A | 5,000 | $1.48 | $7.39K | 35,201 | Direct |
| 21 Jul, 2026 | Gabriele M Cerrone | Director, TenPercentOwner | Acquired A | 22,500 | $1.45 | $32.63K | 10,873,916 | Indirect |
| 21 Jul, 2026 | Gary S Jacob | Chief Development Officer | Acquired A | 3,500 | $1.40 | $4.90K | 112,420 | Direct |
| 22 Jul, 2026 | Robert John Dempsey | Chief Executive Officer | Acquired A | 15,000 | $1.54 | $23.09K | 15,000 | Direct |
| 21 Jul, 2026 | Flavio Mantelli | Chief Medical Officer | Acquired A | 20,000 | $1.40 | $28.00K | 20,000 | Direct |
| 20 Jul, 2026 | Gabriele M Cerrone | Director, TenPercentOwner | Acquired A | 25,000 | $1.40 | $35.00K | 10,851,416 | Indirect |
| 08 Jun, 2026 | Willy Jules Simon | Director | Acquired A | 6,500 | $1.85 | $12.03K | 135,502 | Direct |
| 08 Jun, 2026 | John P Brancaccio | Director | Acquired A | 6,500 | $1.85 | $12.03K | 138,394 | Direct |
| 08 Jun, 2026 | Gabriele M Cerrone | Director, TenPercentOwner | Acquired A | 300,000 | $1.72 | $516.00K | 10,826,416 | Indirect |
| 08 Jun, 2026 | Keeren Rameshchandra Shah | Chief Financial Officer | Acquired A | 40,000 | $1.85 | $74.00K | 544,819 | Direct |
| 08 Jun, 2026 | Bernard Denoyer | Director | Acquired A | 3,500 | $1.85 | $6.48K | 35,190 | Direct |
| 23 Oct, 2023 | Gabriele M Cerrone | Executive Chairman | Acquired J | 499,468 | $1.50 | $749.20K | 9,107,832 | Indirect |